Sitagliptin down-regulates retinol-binding protein 4 and reduces insulin resistance in gestational diabetes mellitus: a randomized and double-blind trial

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Metabolic brain disease

• Publication date

  2017-02-17

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/s11011-017-9958-7PMID 28213841
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Women in India with Gestational Diabetes Mellitus Strategy (WINGS): Methodology and development of model of care for gestational diabetes mellitus (WINGS 4)

  2016cited by this paper
• A concise review of the bioanalytical methods for the quantitation of sitagliptin, an important dipeptidyl peptidase-4 (DPP4) inhibitor, utilized for the characterization of the drug.

  2016cited by this paper
• Reduced DPP4 activity improves insulin signaling in primary human adipocytes.

  2016cited by this paper
• Sitagliptin monotherapy has better effect on insulinogenic index than glimepiride monotherapy in Japanese patients with type 2 diabetes mellitus: a 52-week, multicenter, parallel-group randomized controlled trial

  2016cited by this paper
• Glyburide in Women With Mild Gestational Diabetes: A Randomized Controlled Trial

  2015cited by this paper
• Sitagliptin downregulates retinol-binding protein 4 and upregulates glucose transporter type 4 expression in a type 2 diabetes mellitus rat model.

  2015cited by this paper
• Circulating retinol-binding protein 4 levels in gestational diabetes mellitus: a meta-analysis of observational studies

  2015cited by this paper
• The Relationship between Retinol-Binding Protein 4 Concentrations and Gestational Diabetes Mellitus in Chinese Women

  2015cited by this paper
• Factors predictive of macrosomia in pregnancies with a positive oral glucose challenge test: importance of fasting plasma glucose.

  2014cited by this paper
• RBP4 Gene Variants Are Associated with Insulin Resistance in Women with Previous Gestational Diabetes

  2014cited by this paper
• Significance of RBP4 in patients with gestational diabetes mellitus: a case-control study of Han Chinese women

  2014cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2013cited by this paper
• Adipose Dipeptidyl Peptidase-4 and Obesity Correlation with insulin resistance and depot-speci fi c release from adipose tissue in vivo and in vitro

  2013cited by this paper
• Adipose Dipeptidyl Peptidase-4 and Obesity

  2013cited by this paper
• Mechanisms for the antihyperglycemic effect of sitagliptin in patients with type 2 diabetes.

  2012cited by this paper
• Retinol-binding protein 4 is not associated with insulin resistance in pregnancy.

  2012cited by this paper
• Retinol-binding protein 4, insulin resistance and pregnancy.

  2012cited by this paper
• A randomized, double-blind, placebo-controlled trial evaluating sitagliptin action on insulin resistance parameters and β-cell function

  2012cited by this paper
• Dipeptidyl Peptidase 4 Is a Novel Adipokine Potentially Linking Obesity to the Metabolic Syndrome

  2011cited by this paper
• Diagnosis and Classification of Diabetes Mellitus

  2011cited by this paper
• Prevention of type 2 diabetes induced by high fat diet in the C57BL/6J mouse by two medicinal plants used in traditional treatment of diabetes in the east of Algeria.

  2010cited by this paper
• Retinol-Binding Protein 4 in Patients with Gestational Diabetes Mellitus

  2010cited by this paper
• Normal and abnormal maternal metabolism during pregnancy.

  2009cited by this paper
• A customized standard to assess fetal growth in a US population.

  2009cited by this paper
• Elevated concentrations of retinol-binding protein-4 (RBP-4) in gestational diabetes mellitus: Negative correlation with soluble vascular cell adhesion molecule-1 (sVCAM-1)

  2008cited by this paper
• High plasma retinol binding protein-4 and low plasma adiponectin concentrations are associated with severity of glucose intolerance in women with previous gestational diabetes mellitus.

  2008cited by this paper
• Metabolic changes in pregnancy.

  2007cited by this paper
• Increased Serum Retinol-Binding Protein 4 Concentrations in Women With Gestational Diabetes Mellitus

  2007cited by this paper
• Gestational diabetes and insulin resistance: role in short- and long-term implications for mother and fetus.

  2003cited by this paper
• Retinoid-binding proteins: mediators of retinoid action.

  2000cited by this paper
• Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man

  1985influential reference

• Retinol-binding protein 4 in cardiovascular diseases: mechanisms and therapeutic perspectives

  2026cites this paper
• The Potential Role of Retinol-Binding Protein 4 in Heart Failure: A Review

  2025cites this paper
• The Double-Edged Sword of Gestational Insulin Resistance: Navigating Maternal Adaptation and Its Risks for Pregnancy and Offspring Health.

  2025cites this paper
• Association of DPP-4 Concentrations with the Occurrence of Gestational Diabetes Mellitus and Excessive Gestational Weight Gain

  2024cites this paper
• Targeting Retinol-Binding Protein 4 (RBP4) in the Management of Cardiometabolic Diseases

  2023cites this paper
• Assessing the multitargeted antidiabetic potential of three pomegranate peel‐specific metabolites: An in silico and pharmacokinetics study

  2023cites this paper
• Identifying Candidate Reference Chemicals for In Vitro Testing of the Retinoid Pathway for Predictive Developmental Toxicity

  2022cites this paper
• Incretins as a Potential Treatment Option for Gestational Diabetes Mellitus

  2022influential citation
• Interplay between Fatty Acid Binding Protein 4, Fetuin-A, Retinol Binding Protein 4 and Thyroid Function in Metabolic Dysregulation

  2022cites this paper
• Diabetes: from Research to Clinical Practice: Volume 4

  2021cites this paper
• Retinol-binding protein 4 in obesity and metabolic dysfunctions.

  2021cites this paper
• Adipokines in Insulin Resistance: Current Updates

  2021cites this paper
• Incretin hypersecretion in gestational diabetes mellitus

  2021cites this paper
• Retinol binding protein 4 antagonists and protein synthesis inhibitors: Potential for therapeutic development.

  2021cites this paper
• Retinol-Binding Protein 4 Activates STRA6, Provoking Pancreatic β-Cell Dysfunction in Type 2 Diabetes

  2020cites this paper
• Plasma retinol-binding protein 4 in the first and second trimester and risk of gestational diabetes mellitus in Chinese women: a nested case-control study

  2020cites this paper
• Glucose Lowering Treatment Modalities of Type 2 Diabetes Mellitus.

  2020cites this paper
• Maternal sitagliptin treatment attenuates offspring glucose metabolism and intestinal proinflammatory cytokines IL-6 and TNF-α expression in male rats

  2020cites this paper
• The effect of dipeptidyl peptidase-4 inhibitor and glucagon-like peptide-1 receptor agonist in gestational diabetes mellitus: a systematic review

  2019cites this paper
• Predictive and diagnostic biomarkers for gestational diabetes and its associated metabolic and cardiovascular diseases

  2019cites this paper
• Mechanism of pomegranate ellagic polyphenols reducing insulin resistance on gestational diabetes mellitus rats.

  2019cites this paper
• Pregnancy characteristics as risk factors for future maternal diabetes and other diseases

  2019cites this paper
• Placental extracellular vesicles express active dipeptidyl peptidase IV; levels are increased in gestational diabetes mellitus

  2019cites this paper
• Effects of insulin resistance on the association between the circulating retinol‐binding protein 4 level and clustering of pediatric cardiometabolic risk factors

  2018cites this paper
• Metformin, sitagliptin, and liraglutide modulate serum retinol-binding protein-4 level and adipocytokine production in type 2 diabetes mellitus rat model.

  2018cites this paper
• Use of dipeptidyl peptidase IV inhibitor in the comprehensive management of type 2 diabetes mellitus in Chinese population

  2018cites this paper
• A Prospective Study of Maternal Plasma Concentrations of Retinol-Binding Protein 4 and Risk of Gestational Diabetes Mellitus

  2018cites this paper
• Oral Agents for the Treatment of Gestational Diabetes

  2018cites this paper
• Transcriptomic analysis of Momordica charantia polysaccharide on streptozotocin-induced diabetic rats.

  2018cites this paper